| [1] | Peng ZHANG, Shihao ZHENG, Siyuan GOU, Jinchi XIE, Xianzhao YANG, Yongan YE. The mechanism of compound traditional Chinese medicine prescriptions in reversal of liver fibrosis and early liver cirrhosis[J]. Journal of Clinical Hepatology, 2024, 40(9): 1873-1879. doi: 10.12449/JCH240924 |
| [2] | Hui ZHOU, Bin NIU, Yuqiang MI, Yonggang LIU, Ping LI. Value of serum complement C3 in the diagnosis of liver fibrosis associated with primary biliary cholangitis[J]. Journal of Clinical Hepatology, 2023, 39(11): 2596-2606. doi: 10.3969/j.issn.1001-5256.2023.11.013 |
| [3] | Zhaofang BAI, Xiaoyan ZHAN, Guiji LYU, Yongping YANG. Blocking and reversing liver fibrosis with traditional Chinese medicine compound prescriptions: Beyond the known frontiers[J]. Journal of Clinical Hepatology, 2023, 39(2): 273-277. doi: 10.3969/j.issn.1001-5256.2023.02.004 |
| [4] | ZHANG SuYan, XIA EnRui, ZHOU QingLi, ZHANG ShunZhen. Effect of Quzhi Ruangan decoction on the mRNA and protein expression of organic anion transporting polypeptide 2B1 in the small intestine of rats with nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2020, 36(11): 2484-2488. doi: 10.3969/j.issn.1001-5256.2020.11.017 |
| [5] | Li Yang, Shu DeJun, Peng CiJun, Feng ZanJie, Mei Yong, Xiong Kun. Effect of erythropoietin on the mRNA expression of apoptosis genes bcl-2 and bax in rats with fatty liver disease after hepatic ischemia-reperfusion injury[J]. Journal of Clinical Hepatology, 2019, 35(1): 157-160. doi: 10.3969/j.issn.1001-5256.2019.01.030 |
| [6] | Yang Li, Feng AiDong, Zheng HaoJie, Dai ErHei. Effects of Ruangan Huajian granules on mRNA expression of MMP- 13 and TIMP- 1 in liver tissue among C57 mice with hepatic fibrosis[J]. Journal of Clinical Hepatology, 2014, 30(4): 340-343. doi: 10.3969/j.issn.1001-5256.2014.04.013 |
| [7] | Zhang FenYan, Feng YanMei, Zhu YueKe, Zhang LiJie, Yu HongWei, Li Juan, Fu WanFa, Meng QingHua. Roles of GCK mRNA and GLUT2 in abnormal glucose metabolism among patients with severe chronic hepatitis B[J]. Journal of Clinical Hepatology, 2013, 29(8): 607-610. doi: 10.3969/j.issn.1001-5256.2013.08.014 |
| [8] | Li ZhangZheng, Hu WenWei, Li Wen, Li QingShan, Liu QuanDa, Cheng LiuFang, Zhou NingXin. Effect of time of biliary drainage on biliary obstructive liver fibrosis in rats[J]. Journal of Clinical Hepatology, 2011, 27(9): 944-946. |
| [10] | Hu TaiHong, Jiang XiangHu, Jiang YueMing, Zhou Min, Xu Min, Zhu Rui, Yang Ling. Expression of NF-κB and ERK-1mRNA in rat with liver fibrosis[J]. Journal of Clinical Hepatology, 2009, 25(1): 23-25. |
| [12] | Liao Dan, Jiang JianNing, Luo GuangHan, Wu JiZhou. The expression and significance of TGF-β1 and smad4m RNA in chronic viral hepatitis and cirrhosis[J]. Journal of Clinical Hepatology, 2005, 21(2): 89-91. |
| [13] | Zhao XinYan, Wang BaoEn, Wang TaiLing, Jia JiDong, Ma XueMei. Comparative study of the effect of two different herbal compounds on CCl4 induced liver fibrosis in rats.[J]. Journal of Clinical Hepatology, 2005, 21(1): 21-24. |
| [14] | Shen FengJun, Yin ChengHong, Zhu YueKe, Jia JiDong, Wang BaoEn. MMP2 gene expression and the effect of angiotensin II type l receptor blocker valsartan on DMN hepatic fibrosis model[J]. Journal of Clinical Hepatology, 2005, 21(1): 19-20. |
| [16] | Yin ChengHong, Ma Hong, Wang AiMin, Ma XueMei, Jia JiDong, Wang BaoEn. Effect of compound 861 on stromelysin gene expression of HSC-T6 cell[J]. Journal of Clinical Hepatology, 2002, 18(3): 168-170. |
| [17] | Shen FengJun, Yin ChengHong, Ma Hong, Ma XueMei, Jia JiDong, Wang BaoEn, Zhu YueKe, Liu TianHui. Expression of angiotensin Ⅱ type 1 receptors mRNA in rat experimental biliary fibrosis[J]. Journal of Clinical Hepatology, 2002, 18(5): 279-281. |
| [18] | Yang ZhangQing, Hu GuoLing, Tan DeMing, Zhang Zheng. Relativity of Expression of MMP-1、TIMP-1 and Variability of Type Ⅰ、Ⅲ Collagen During Experimental Liver Fibrosis[J]. Journal of Clinical Hepatology, 2000, 16(4): 222-224. |
DownLoad: